Corrigendum to “Adjuvant and first line chemotherapy use for endometrial cancer” [Gynecol. Oncol. Rep. 41 (2022) 101002]

• Anne Knisely,
• Yongmei Huang,
• Yeran Li,
• Vimalanand S. Prabhu,
• Jason D. Wright

Affiliations

Anne Knisely

Columbia University College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA

Yongmei Huang

Columbia University College of Physicians and Surgeons, USA

Yeran Li

Merck & Co., Inc., Kenilworth, NJ, USA

Vimalanand S. Prabhu

Merck & Co., Inc., Kenilworth, NJ, USA

Jason D. Wright

Columbia University College of Physicians and Surgeons, USA; Herbert Irving Comprehensive Cancer Center, USA; New York Presbyterian Hospital, USA; Corresponding author at: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, 161 Fort Washington Ave, 8th Floor, New York, NY 10032, USA.